US Patent No. 9,499,820

Methods of eliminating or reducing expression of genes in filamentous fungal strains by transitive RNA interference
Dec 08, 2016

Novozymes has been awarded US Patent No. 9,499,820, "Methods of eliminating or reducing expression of genes in filamentous fungal strains by transitive RNA interference."

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.